World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
86
Citations
37632
World Ranking
819
National Ranking
379

Medicine

D-Index
88
Citations
39824
World Ranking
12945
National Ranking
6618

Kenji Ikeda publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kenji Ikeda sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 560 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kenji Ikeda D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kenji Ikeda sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 86 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kenji Ikeda is affiliated with the University of California, San Francisco in the United States. Their primary field of study is Medicine, with a focus on several subfields including Epidemiology, Hepatology, Endocrinology, Diabetes and Metabolism, Cognitive Neuroscience, and Experimental and Cognitive Psychology.

The scientist has contributed extensively to research in topics such as Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatitis C Virus Research, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, Memory Processes and Influences, and Diet, Metabolism, and Disease.

Kenji Ikeda's recent papers include:

  • "Wireless optogenetics protects against obesity via stimulation of non-canonical fat thermogenesis" (2020), published in Nature Communications
  • "SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology" (2020), published in Internal Medicine
  • "Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study" (2022), published in Hepatology Communications
  • "Potential of ultra-highly sensitive immunoassays for hepatitis B surface and core-related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance" (2020), published in Hepatology Research
  • "Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir" (2021), published in Hepatology Communications

The frequent co-authors collaborating with Kenji Ikeda are:

  • Norio Akuta
  • Yusuke Kawamura
  • Hitomi Sezaki
  • Tetsuya Hosaka
  • Fumitaka Suzuki

Kenji Ikeda's research is often published in venues including:

  • Hepatology Research
  • Oncology
  • Metacognition and Learning
  • Kanzo
  • Hepatology Communications

Best Publications

  • Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

    Masatoshi Kudo;Richard S. Finn;Shukui Qin;Kwang Hyub Han

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix

  • Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

    Yujin Hoshida;Sebastian M.B. Nijman;Sebastian M.B. Nijman;Masahiro Kobayashi;Jennifer A. Chan;Jennifer A. Chan

  • A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

    M D Kenji Ikeda;Satoshi Saitoh;Isao Koida;Yasuji Arase

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • The long-term pathological evolution of chronic hepatitis C

    M Yano;H Kumada;M Kage;K Ikeda

  • Factors predictive of response to interferon‐α therapy in hepatitis C virus infection

    Akihito Tsubota;Kazuaki Chayama;Kenji Ikeda;Arase Yasuji

  • Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

    Kenji Ikeda;Satoshi Saitoh;Yasuji Arase;Kazuaki Chayama

  • Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

    Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota

  • UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis.

    Kenji Ikeda;Qianqian Kang;Takeshi Yoneshiro;Joao Paulo Camporez

  • The Common and Distinct Features of Brown and Beige Adipocytes

    Kenji Ikeda;Pema Maretich;Shingo Kajimura

  • Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

    Kenji Ikeda;Satoshi Saitoh;Yoshiyuki Suzuki;Masahiro Kobayashi

  • Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

    Kazuaki Chayama;Yoshiyuki Suzuki;Masahiro Kobayashi;Mizuho Kobayashi

  • BCAA catabolism in brown fat controls energy homeostasis through SLC25A44.

    Takeshi Yoneshiro;Qiang Wang;Kazuki Tajima;Mami Matsushita

  • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer

    Kenji Ikeda;Yasuji Arase;Satoshi Saitoh;Masahiro Kobayashi

  • Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders†‡§

    Kazuaki Chayama;Shoichi Takahashi;Joji Toyota;Yoshiyasu Karino

  • The long term efficacy of glycyrrhizin in chronic hepatitis C patients

    Unknown

  • Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.

    Kenji Ikeda;Masatoshi Kudo;Seiji Kawazoe;Yukio Osaki

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • RAPID COMMUNICATION Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection

    Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Yasuji Arase
Yasuji Arase University of Yamanashi
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Hitomi Sezaki
Hitomi Sezaki Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Kazuaki Chayama
Kazuaki Chayama Hiroshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open up diverse career opportunities. Programs like the easy admission online MPH programs offer a practical route into public health, blending biology with community health initiatives.

Career paths such as becoming a child.life specialist salary reflect interdisciplinary roles that combine medical knowledge with psychological support, ideal for those who want to make a direct impact on children's wellbeing.

Accessibility is another important consideration. Prospective students with unique backgrounds can find options at online colleges that accept felons, ensuring education remains inclusive and available to a wider audience.

For those leaning toward healthcare, specialized tracks like functional medicine np programs provide advanced training focused on integrative and holistic patient care, complementing a microbiology foundation with clinical expertise.

Best Scientists Citing Kenji Ikeda

Trending Scientists

Recently Published Articles